EliteImmune

Customized reagents and services for monoclonal antibody development

EliteImmune is developing antibody-based drugs for targeted therapy of infectious diseases. EliteImmune has developed a suite of technologies to streamline the discovery of therapeutic antibodies. This includes CellSortTM, an integrated antigen-specific single B cell manipulation and characterization platform that can be used to identify rare antibodies with high therapeutic value. Using CellSortTM and CellSeqTM, EliteImmune’s computational platform, they have created a pipeline of broadly neutralizing antibodies for infectious diseases. EliteImmune’s lead candidate is against the respiratory syncytial virus that was derived by optimizing a human monoclonal antibody isolated from an elite donor.